Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, Guidelines, Atrial fibrillation, Anticoagulation, Vitamin K antagonists, Non-vitamin K antagonist oral anticoagulants, Left atrial appendage occlusion, Rate control, Cardioversion, Rhythm control, Antiarrhythmic drugs, Upstream therapy, Catheter ablation, AF surgery, Valve repair, Pulmonary vein isolation, Left atrial ablation, PULMONARY-VEIN ISOLATION, QUALITY-OF-LIFE, RADIOFREQUENCY CATHETER ABLATION, WOLFF-PARKINSON-WHITE, TRANSIENT ISCHEMIC ATTACK, OBSTRUCTIVE SLEEP-APNEA, VITAMIN-K ANTAGONISTS, LONG-QT-SYNDROME, POLYUNSATURATED FATTY-ACIDS, ANTIARRHYTHMIC-DRUG THERAPY, Atrial Fibrillation, Cardiology, Europe, Humans, Societies, Medical, ESC Scientific Document Group, VALVULAR HEART-DISEASE, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology, 3201 Cardiovascular medicine and haematology, 3202 Clinical sciences